Mark Your Calendar for EU Pharmaceutical Law Forum 2024!
May 21-23, 2024Steigenberger Wiltcher's, BrusselsMark Your Calendar for EU Pharmaceutical Law Forum 2024!
May 21-23, 2024,
Steigenberger Wiltcher's, Brussels
Thursday 25 May 2023
Commercial Transactions: What Are Killing Commercial Deals?
Reinvigorate Your Commercial Agreements And Discover Practical Tips To Drive Success Across Licensing, M&A, Joint Ventures and Investments.
Tools and Techniques For Effective Commercial Transactions
Transaction Trends and Deal Landscape in the Life Sciences Sector:
- Hot Investment Sectors In The Life Science Sector
- Update On Deal Structures, Spin offs, and Cross-Border Deals
- Access To Capital Through New Financial Vehicles And Their Impact On Transactions
- How Is Competition Between Pharma Companies And Institutional Investors For Biotech Platforms Evolving?
Take Away Expert Advice On:
- Managing Delays And Costs Resulting From Foreign Direct Investment Screening In US and EU
- Structuring Contracts To Minimise Risk For R&D Agreements And Licensing Of IP
- How To Circumnavigate Antitrust Risk For Transactions And Filings
- Key Market Insight: What Are Killing Commercial Deals?
Drive Success In Your Commercial Agreements:
- Constructing Value For Platform Technology In IP Licensing Negotiations
- New Developments And Risk Management In Digital Data Deals
- Discussing Challenging Risks In License Collaboration, True JVs, M&A and Investment Deals
- How To Balance Antitrust Considerations With Commercial Reasons To Share Information
